Last Update 05 Jun 26
Fair value Decreased 0.043%CME: Crypto And AI Futures Expansion Will Shape Future Earnings Power
Analysts have trimmed their average price target for CME Group to about $306.47. This reflects concerns that revenue momentum could soften as geopolitical volatility eases and that fresh competition in bitcoin perpetual futures may weigh on exchange valuations, even as several firms still see the competitive risk as manageable.
Analyst Commentary
Recent research on CME Group reflects a split view, with some analysts focusing on risks to trading volumes and competition, while others have adjusted price targets in both directions as they reassess growth and valuation.
Bullish Takeaways
- Bullish analysts who recently raised price targets point to CME's existing revenue momentum as a base case for their models, even if they now see that momentum as potentially moderating over time.
- Supportive views emphasize CME's established derivatives franchise and structural advantages in listed futures, which some analysts believe help the company compete against new offerings such as bitcoin perpetual futures.
- RBC describes the competitive risk from CFTC approved bitcoin perpetual futures as "manageable" for CME, citing product differences and structural factors that, in their view, support the exchange's execution and positioning.
- Several neutral to positive ratings, including Sector Perform or Market Perform stances, suggest that some analysts see CME's current valuation as broadly aligned with its execution record and risk profile, rather than structurally impaired.
Bearish Takeaways
- Bearish analysts have shifted ratings or targets lower on the view that if geopolitical uncertainties fade, trading volumes and transaction fees may soften, which could pressure revenue trends that have been supportive up to now.
- The CFTC's approval of bitcoin perpetual futures for a rival venue has raised concerns about increased competition, with some research pointing to potential pressure on valuation multiples for exchange stocks, including CME.
- Commentary around the new bitcoin perpetual futures highlights particular concern for exchange peers such as Cboe, with CME also mentioned as exposed to incremental competition in parts of the retail focused futures market.
- Target cuts from several firms indicate that a group of cautious analysts is recalibrating growth and earnings assumptions, which feeds into a more conservative view on how much investors may be willing to pay for CME's stock in the near term.
What's in the News
- CME Group and Silicon Data plan to launch what they describe as the first futures market for AI computing power in 2026, using Silicon Data’s daily GPU price indices to create standardized compute futures for traders, financial institutions, AI developers and cloud providers (Primary source).
- CME has started 24/7 trading for its cryptocurrency futures and options suite on CME Globex, with more than 7,200 contracts, or about US$50m in notional value, traded during the first weekend of round the clock access and Bitcoin Volatility futures now also trading 24/7 (Primary source, Key Developments).
- The company reported record May 2026 average daily volume of 33.2 million contracts, a 15% year over year change, alongside Q1 revenue that management reports was at a record level with a 14% year over year change and adjusted EPS of US$3.36, while adjusted operating margin was 72.8% (Primary source).
- CME is expanding its crypto offering with Nasdaq CME Crypto Index futures scheduled for June 8, 2026 and additional contracts such as Avalanche (AVAX) and Sui (SUI) futures, giving traders more index based and single coin tools in regulated markets (Primary source, Key Developments).
- Shares of CME and other exchanges declined after the CFTC approved Kalshi’s Bitcoin perpetual futures, fueling debate over competitive pressure and systemic risk, with TD Cowen flagging potential valuation pressure and RBC describing the competitive threat as manageable, and CME CEO Terry Duffy publicly criticizing regulators’ stance on perpetual crypto products (Primary source).
Valuation Changes
- Fair Value: The modelled fair value estimate is essentially unchanged at about $306.47, compared with the prior $306.60.
- Discount Rate: The discount rate has fallen slightly from 7.85% to about 7.77%, indicating a modest adjustment in the required return used in the analysis.
- Revenue Growth: The revenue growth assumption is now about 5.14%, very close to the previous 5.13%, so the outlook used in the model remains broadly consistent.
- Net Profit Margin: The net profit margin input is now about 58.35%, compared with 58.37% previously, which is a minimal change.
- Future P/E: The future P/E multiple has eased slightly from about 30.95x to 30.87x, reflecting a marginally lower valuation multiple in the updated assumptions.
Key Takeaways
- Strong global demand for risk management, retail engagement, and international expansion drives volume and revenue growth, diversifying CME's client base.
- Innovation in products, technology, and partnerships enhances efficiency and margins, positioning CME for sustainable long-term earnings growth.
- Competitive threats from DeFi, regulatory shifts, and low volatility could erode CME Group's market share, trading volumes, and profit margins over time.
Catalysts
About CME Group- Operates contract markets for the trading of futures and options on futures contracts worldwide.
- Heightened global macroeconomic uncertainty, record sovereign debt issuance, persistent geopolitical tensions, and ongoing trade disputes are fueling sustained demand for risk management and hedging solutions, evidenced by record contract volumes and open interest; this trend is likely to support continued revenue and fee growth.
- Robust international expansion-with record-breaking double-digit ADV growth across EMEA and APAC and rising participation from both institutional and retail clients globally-broadens CME's addressable market and underpins future volume and revenue growth.
- The rapid acceleration of retail engagement, highlighted by a 56% increase in new retail traders and five consecutive quarters of double-digit retail client acquisition growth, diversifies CME's client base and supports both volume and transaction-based revenue growth.
- New product innovations (e.g., Micro contracts, expansion into crypto, FX Spot+), ongoing tech-driven operating efficiencies (cloud migration and tokenization initiatives), and strengthening of strategic partnerships (such as the long-term NASDAQ index license extension and Google Cloud collaboration) are enhancing operating leverage and EBITDA/net margin performance.
- The ongoing global shift toward electronic trading, greater regulatory demands for transparency and standardized clearing, and a proven ability to grow non-transactional revenue (e.g., record market data revenue) position CME to capture a larger share of trading activity and support durable long-term earnings growth.
CME Group Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming CME Group's revenue will grow by 5.1% annually over the next 3 years.
- Analysts assume that profit margins will shrink from 62.9% today to 58.4% in 3 years time.
- Analysts expect earnings to reach $4.6 billion (and earnings per share of $13.27) by about June 2029, up from $4.2 billion today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 30.9x on those 2029 earnings, up from 21.9x today. This future PE is lower than the current PE for the US Capital Markets industry at 39.1x.
- Analysts expect the number of shares outstanding to grow by 0.55% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.77%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Prolonged periods of geopolitical stability and reduced headline risk could curb market volatility, lowering overall demand for risk-hedging and derivatives trading, which may lead to declining trading volumes and negatively impact CME Group's revenue and earnings growth.
- The accelerating adoption of decentralized finance (DeFi) and tokenization technologies poses a long-term competitive threat, as new market structures could enable trading and settlement of derivatives outside of centralized venues like CME, potentially reducing future market share and fee revenues.
- CME's continued heavy reliance on trading activity in interest rate and equity futures exposes the company to periods of subdued volatility or volume in those sectors, which could result in revenue stagnation or contraction and put pressure on net margins.
- Regulatory changes-such as potential increased oversight of retail derivatives trading, limitations on certain products (e.g., perpetuals in the U.S.), or global moves to further tighten derivatives market participation-may dampen speculative activity and reduce overall transaction fees and open interest.
- Intensifying industry competition from alternative electronic trading venues, lower-fee platforms, and the proliferation of OTC derivatives and algorithmic solutions could create sustained pricing pressure, eroding net margins and constraining CME's long-term earnings growth.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $306.47 for CME Group based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $353.0, and the most bearish reporting a price target of just $230.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $7.8 billion, earnings will come to $4.6 billion, and it would be trading on a PE ratio of 30.9x, assuming you use a discount rate of 7.8%.
- Given the current share price of $256.06, the analyst price target of $306.47 is 16.4% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on CME Group?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.